BVNRY
Price
$12.31
Change
-$0.01 (-0.08%)
Updated
Aug 29 closing price
Capitalization
2.88B
MBXBF
Price
$0.17
Change
-$0.00 (-0.00%)
Updated
Aug 29 closing price
Capitalization
23.91M
Interact to see
Advertisement

BVNRY vs MBXBF

Header iconBVNRY vs MBXBF Comparison
Open Charts BVNRY vs MBXBFBanner chart's image
Bavarian Nordic A/S
Price$12.31
Change-$0.01 (-0.08%)
Volume$876
Capitalization2.88B
Microbix Biosystems
Price$0.17
Change-$0.00 (-0.00%)
Volume$615.09K
Capitalization23.91M
BVNRY vs MBXBF Comparison Chart in %
Loading...
BVNRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBXBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BVNRY vs. MBXBF commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVNRY is a Hold and MBXBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (BVNRY: $12.31 vs. MBXBF: $0.17)
Brand notoriety: BVNRY and MBXBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVNRY: 10% vs. MBXBF: 854%
Market capitalization -- BVNRY: $2.88B vs. MBXBF: $23.91M
BVNRY [@Biotechnology] is valued at $2.88B. MBXBF’s [@Biotechnology] market capitalization is $23.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVNRY’s FA Score shows that 0 FA rating(s) are green whileMBXBF’s FA Score has 1 green FA rating(s).

  • BVNRY’s FA Score: 0 green, 5 red.
  • MBXBF’s FA Score: 1 green, 4 red.
According to our system of comparison, BVNRY is a better buy in the long-term than MBXBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVNRY’s TA Score shows that 4 TA indicator(s) are bullish while MBXBF’s TA Score has 3 bullish TA indicator(s).

  • BVNRY’s TA Score: 4 bullish, 4 bearish.
  • MBXBF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BVNRY is a better buy in the short-term than MBXBF.

Price Growth

BVNRY (@Biotechnology) experienced а -0.98% price change this week, while MBXBF (@Biotechnology) price change was +2.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.61%. For the same industry, the average monthly price growth was +22.15%, and the average quarterly price growth was +32.80%.

Industries' Descriptions

@Biotechnology (+6.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BVNRY($2.88B) has a higher market cap than MBXBF($23.9M). MBXBF has higher P/E ratio than BVNRY: MBXBF (22.25) vs BVNRY (13.16). BVNRY YTD gains are higher at: 41.454 vs. MBXBF (-40.381). BVNRY has higher annual earnings (EBITDA): 2.01B vs. MBXBF (4.35M). BVNRY has more cash in the bank: 1.24B vs. MBXBF (14.5M). MBXBF has less debt than BVNRY: MBXBF (5.35M) vs BVNRY (117M). BVNRY has higher revenues than MBXBF: BVNRY (6.23B) vs MBXBF (22.7M).
BVNRYMBXBFBVNRY / MBXBF
Capitalization2.88B23.9M12,050%
EBITDA2.01B4.35M46,285%
Gain YTD41.454-40.381-103%
P/E Ratio13.1622.2559%
Revenue6.23B22.7M27,449%
Total Cash1.24B14.5M8,524%
Total Debt117M5.35M2,187%
FUNDAMENTALS RATINGS
BVNRY vs MBXBF: Fundamental Ratings
BVNRY
MBXBF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
73
Overvalued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
6384
PRICE GROWTH RATING
1..100
4292
P/E GROWTH RATING
1..100
968
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BVNRY's Valuation (45) in the null industry is in the same range as MBXBF (73). This means that BVNRY’s stock grew similarly to MBXBF’s over the last 12 months.

BVNRY's Profit vs Risk Rating (94) in the null industry is in the same range as MBXBF (100). This means that BVNRY’s stock grew similarly to MBXBF’s over the last 12 months.

BVNRY's SMR Rating (63) in the null industry is in the same range as MBXBF (84). This means that BVNRY’s stock grew similarly to MBXBF’s over the last 12 months.

BVNRY's Price Growth Rating (42) in the null industry is somewhat better than the same rating for MBXBF (92). This means that BVNRY’s stock grew somewhat faster than MBXBF’s over the last 12 months.

MBXBF's P/E Growth Rating (8) in the null industry is significantly better than the same rating for BVNRY (96). This means that MBXBF’s stock grew significantly faster than BVNRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BVNRYMBXBF
RSI
ODDS (%)
Bearish Trend 5 days ago
64%
Bullish Trend 5 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
62%
Bullish Trend 5 days ago
67%
Momentum
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 5 days ago
74%
MACD
ODDS (%)
Bearish Trend 5 days ago
71%
Bearish Trend 5 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
72%
Bullish Trend 5 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
67%
Bearish Trend 5 days ago
78%
Advances
ODDS (%)
Bullish Trend 26 days ago
70%
N/A
Declines
ODDS (%)
Bearish Trend 19 days ago
73%
Bearish Trend 20 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
59%
Bullish Trend 5 days ago
55%
Aroon
ODDS (%)
Bullish Trend 5 days ago
67%
Bearish Trend 5 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
BVNRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBXBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VYCFX26.51-0.05
-0.19%
Voya Corporate Leaders 100 R
SGIDX37.96-0.16
-0.42%
Steward Global Equity Income Fund A
CWGFX72.57-0.43
-0.59%
American Funds Capital World Gr&Inc F1
GCTIX51.56-0.32
-0.62%
Goldman Sachs US Tax-Managed Eq Instl
JACDX10.57-0.08
-0.75%
JHancock Global Environmental Opps R6

BVNRY and

Correlation & Price change

A.I.dvisor tells us that BVNRY and GOVX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVNRY and GOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVNRY
1D Price
Change %
BVNRY100%
-0.08%
GOVX - BVNRY
28%
Poorly correlated
+0.15%
ALZN - BVNRY
25%
Poorly correlated
+0.41%
VRAX - BVNRY
24%
Poorly correlated
-1.48%
CRMD - BVNRY
20%
Poorly correlated
+3.34%
MBXBF - BVNRY
20%
Poorly correlated
-0.98%
More

MBXBF and

Correlation & Price change

A.I.dvisor tells us that MBXBF and CMND have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBXBF and CMND's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBXBF
1D Price
Change %
MBXBF100%
-0.98%
CMND - MBXBF
25%
Poorly correlated
+3.43%
BVNRY - MBXBF
20%
Poorly correlated
-0.08%
MMIRF - MBXBF
15%
Poorly correlated
-10.00%
IVEVF - MBXBF
8%
Poorly correlated
N/A
IVBXF - MBXBF
7%
Poorly correlated
N/A
More